A Pilot Study for Efficacy of Cognitive and Physical Training in Patients With Mild Cognitive Impairment
NCT ID: NCT06355973
Last Updated: 2024-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
24 participants
INTERVENTIONAL
2024-04-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is for the prevention and treatment of dementia in the future. randomized, Pilot Study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Combining Physical Exercise and Cognitive Training for Individuals With Mild Cognitive Impairment
NCT03619577
Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient
NCT01553929
Effects of Combined Physical-cognitive Training on Cognitive Function in MCI
NCT03805620
Evolving Methods to Combine Cognitive and Physical Training for Individuals With Mild Cognitive Impairment
NCT02512627
Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project
NCT04498195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Using tablets and workbooks.
Using tablets and workbooks Cognitive and physical function training self-programming for 6 weeks.
Using tablets and workbooks cognitive function.
Cognitive training programs corresponding to memory, attention, time and space, and orientation are conducted for 35 to 60 minutes.
self-programming of physical function training.
The fitness program consisting of stretching, muscle strength, coordination, and aerobic exercise lasts 20 to 30 minutes, and additional 3-4 times/mainly 30 to 40 minutes of aerobic exercise.
Only self-programming of physical function training.
Only self-programming of physical function training is provided Implemented for 6 weeks.
self-programming of physical function training.
The fitness program consisting of stretching, muscle strength, coordination, and aerobic exercise lasts 20 to 30 minutes, and additional 3-4 times/mainly 30 to 40 minutes of aerobic exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Using tablets and workbooks cognitive function.
Cognitive training programs corresponding to memory, attention, time and space, and orientation are conducted for 35 to 60 minutes.
self-programming of physical function training.
The fitness program consisting of stretching, muscle strength, coordination, and aerobic exercise lasts 20 to 30 minutes, and additional 3-4 times/mainly 30 to 40 minutes of aerobic exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A person who falls within the abnormal range of the Montreal Cognitive Assessment (MoCA) test
3. a person who can independently carry out daily life
4. If the subject or legal representative voluntarily decides to participate and agrees in writing to comply with the precautions after hearing and fully understanding the detailed explanation of this clinical study
Exclusion Criteria
2. A person with unstable cardiovascular system, digestive system, respiratory system, endocrine system, etc. and poor general condition
3. Patients who have participated in other treatment clinical studies or who have participated in other treatment clinical studies within the last 30 days
4. Other cases where the researcher determines that participation in this clinical study is not appropriate
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MinYoung Kim, MD, PhD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MinYoung Kim, MD, PhD
Sponsor-Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MinYoung Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHA Bundang Medical Center
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-01-061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.